BIOINKS
20210393850 · 2021-12-23
Inventors
Cpc classification
B33Y10/00
PERFORMING OPERATIONS; TRANSPORTING
B29L2031/753
PERFORMING OPERATIONS; TRANSPORTING
B33Y70/00
PERFORMING OPERATIONS; TRANSPORTING
B29K2995/0082
PERFORMING OPERATIONS; TRANSPORTING
C08B37/0084
CHEMISTRY; METALLURGY
C08J3/24
CHEMISTRY; METALLURGY
B29K2005/00
PERFORMING OPERATIONS; TRANSPORTING
B29C64/106
PERFORMING OPERATIONS; TRANSPORTING
B33Y80/00
PERFORMING OPERATIONS; TRANSPORTING
International classification
B29C64/106
PERFORMING OPERATIONS; TRANSPORTING
B33Y70/00
PERFORMING OPERATIONS; TRANSPORTING
B33Y80/00
PERFORMING OPERATIONS; TRANSPORTING
C08J3/24
CHEMISTRY; METALLURGY
Abstract
The present invention relates to a hydrogel comprising an oxidized alginate containing aldehyde groups, wherein the oxidized alginate is crosslinked with an imine type crosslinker. The hydrogel is particularly suitable as a bioink, i.e. for 3D printing of cell structures. The gels provide good printability and exhibit excellent viscoelasticity, shear thinning and self-healing characteristics.
Claims
1. A hydrogel comprising an oxidized alginate containing aldehyde groups, wherein the oxidized alginate has a molecular weight Mw of 80,000 daltons or more and the oxidized alginate is crosslinked with an imine type crosslinker selected from the group consisting of: an alkoxy compound having formula (I): ##STR00033## wherein m is 2 to 12, a semicarbazide compound having formula (II): ##STR00034## wherein n is 2 to 12, and a hydrazide compound having formula (III): ##STR00035## wherein p is 2 to 12; wherein ##STR00036## represents an alkylene group having m, n or p carbon atoms, wherein 1 or more carbon atoms can be replaced by a heteroatom selected from O, S and N; a compound having formula (IV): ##STR00037## wherein x is 1 to 20; a compound having formula (V): ##STR00038## wherein y is 1 to 20; a compound having formula (VI): ##STR00039## wherein z is 1 to 20; a compound having formula (VII) ##STR00040## a compound having formula (VIII) ##STR00041## a compound having formula (IX): ##STR00042## a compound having formula (X): ##STR00043## a compound having formula (XI) ##STR00044## and a compound having formula (XII): ##STR00045##
2. The hydrogel according to claim 1, wherein ##STR00046## represents an alkylene group having m, n or p carbon atoms.
3. The hydrogel according to claim 1, wherein the oxidized alginate has a molecular weight M.sub.w of 100,000 daltons or more.
4. The hydrogel according to claim 1, wherein the oxidized alginate is crosslinked with an imine type crosslinker selected from the group consisting of the compound having formula (I), the compound having formula (II) and the compound having formula (III).
5. The hydrogel according to claim 4, wherein the oxidized alginate is crosslinked with an imine type crosslinker having a structure: ##STR00047##
6. The hydrogel according to claim 1, wherein the oxidation level is 2% to 20%.
7. The hydrogel according to claim 1, wherein the alginate is 2% to 20% cross-linked.
8. The hydrogel according to claim 1, containing human or animal cells.
9. A method comprising: using the hydrogel according to claim 1 to grow human or animal cells.
10. A reservoir containing the hydrogel according to claim 1, wherein the reservoir has a volume of at least 1 mL.
11. A method for manufacturing a 3D hydrogel structure comprising the steps of: a) providing a suspension of an oxidized alginate containing aldehyde groups in a medium, wherein the oxidized alginate has a molecular weight M.sub.w of 50,000 daltons or more; b) adding an imine type crosslinker selected from the group consisting of an alkoxy compound having formula (I): ##STR00048## wherein m is 2 to 12, a semicarbazide compound having formula (II): ##STR00049## wherein n is 2 to 12, and a hydrazide compound having formula (III): ##STR00050## wherein p is 2 to 12 wherein ##STR00051## represents an alkylene group having m, n or p carbon atoms, wherein 1 or more carbon atoms can be replaced by a heteroatom selected from O, S and N; a compound having formula (IV): ##STR00052## wherein x is 1 to 20; a compound having formula (V): ##STR00053## wherein y is 1 to 20; a compound having formula (VI): ##STR00054## wherein z is 1 to 20; a compound having formula (VII) ##STR00055## a compound having formula (VIII) ##STR00056## a compound having formula (IX): ##STR00057## a compound having formula (X): ##STR00058## a compound having formula (XI) ##STR00059## and a compound having formula (XII): ##STR00060## c) allowing a gel to form; d) depositing the gel obtained in step c) layer by layer on a surface according to a predefined structure.
12. The method according to claim 11, wherein ##STR00061## represents an alkylene group having m, n or p carbon atoms.
13. The method according to claim 11, wherein the imine type crosslinker is selected from a compound having a structure of Formula (I), Formula (II) or Formula (III).
14. The method according to claim 13, wherein the imine type crosslinker is selected from a compound having a structure: ##STR00062##
15. The method according to claim 11, wherein step a) further includes adding cells to the oxidized alginate containing aldehyde groups.
Description
DESCRIPTION OF THE FIGURES
[0080]
[0081]
[0082]
[0083]
[0084]
[0085]
[0086]
[0087]
[0088]
[0089]
[0090]
[0091]
[0092]
EXPERIMENTAL
Materials
[0093] Propanoic acid hydrazide (≥90%), O-ethylhydroxylamine hydrochloride (97%), adipic acid dihydrazide (≥98%, AADH), O,O′-1,3-propanediylbishydroxylamine dihydrochloride (98%, PDHA), activated charcoal (Norit), sodium periodate (NaIO4), ethylene glycol, and Dulbecco's modified Eagle's medium-F12 (DMEM-F12, low glucose) were purchased from Sigma-Aldrich. N,N′-(hexane-1,6-diyl)bis(hydrazinecarboxamide) (HDCA) was synthesized according to Sims, M. B.; Patel, K. Y.; Bhatta, M.; Mukherjee, S.; Sumerlin, B. S. Harnessing Imine Diversity to Tune Hyperbranched Polymer Degradation. Macromolecules 2018, 51, 356-363, doi:10.1021/acs.macromo1.7b02323.
[0094] Dulbecco's phosphate buffer saline (PBS), fetal bovine serum (FBS), penicillin/streptomycin (P/S), calcein AM, ethidium homodimer and PrestoBlue™ cell viability reagent were purchased from Thermo Fisher Scientific. Dialysis membrane (Spectra/Por®) with molecular weight cut off (MWCO) 3500 Dalton (Da) was obtained from VWR, Netherlands.
[0095] Sodium alginate was purchased from FMC (Manugel GMB, Lot No. G9402001). Mn was determined as 258,439 and Mw was determined as 518,701.
[0096] RGD used was prepared according to Zamuner, A.; Cavo, M.; Scaglione, S.; Messina, G. M. L.; Russo, T.; Gloria, A.; Marietta, G.; Dettin, M. Design of decorated self-assembling peptide hydrogels as architecture for mesenchymal stem cells. Materials (Basel). 2016, 9, doi:10.3390/ma9090727 and had the following structure:
##STR00032##
[0097] Based on high temperature NMR (370K), estimation for G and M blocks in this alginate is 74% and 26% respectively. Calculations carried out on estimations of block compositions were based on the report by Grasdalen (Grasdalen, H. High-Field, 1H-N.M.R. Spectroscopy of Alginate: Sequential Structure and Linkage Conformations. Carbohydr. Res. 1983, 118, 255-260) and Penman (Penman, A.; Sanderson, G. R. A Method for the Determination of Uronic Acid Sequence in Alginates. Carbohydr. Res. 1972, 25 (2), 273-282.)
Alginate Purification
[0098] Alginate powder was dissolved in deionized (DI) water at a concentration of 1% (w/v). Activated charcoal (1% (w/v)) was added, and the alginate solution was stirred for 24 h at 4° C. Subsequently, the alginate solution was filtered with 11 μm, 1.2 μm, 0.45 μm, and 0.2 μm Whatman membrane filters to remove charcoal particles. The alginate solution was then frozen and lyophilized.
Synthesis of Oxidized Alginate
Example 1; 5% Oxidation
[0099] Purified alginate (1.00 g, 5.68×10.sup.−3 mol monomer) was dissolved in 100 mL DI water. Keeping the reaction in the dark, sodium periodate (6.07×10.sup.−2 g, 2.84×10.sup.−4 mole) was added in one portion with stirring. After 17 hours in the dark (at RT), the reaction was quenched by addition of ethylene glycol (1.76×10.sup.−2 g, 2.84×10.sup.−4 mole, equimolar to NaIO.sub.4). The reaction solution was stirred in dark for a 1 hr to stop the reaction completely. The reaction solution was dialyzed against water using membrane tubes of MWCO 3500 Da (3 days with 3× water change per day), then lyophilized yielding a white fibrous material (above 80% yield).
Example 2, 10% Oxidation
[0100] A similar procedure as Example 1 was followed, except that (1.21×10.sup.−1 g, 5.68×10.sup.−4 mole) sodium periodate was used. Yield was above 80%:
Example 3, 15% Oxidation
[0101] A similar procedure as Example 1 was followed, except that (1.82×10.sup.−1 g, 8.52×10.sup.−4 mole) sodium periodate was used. Yield was above 80%:
[0102] The oxidation of alginate in Examples 1 to 3 was confirmed by the presence of hemiacetal peaks in the NMR spectra and it was found that with an increase in the degree of oxidation, the hemiacetal peak intensity increased. This is shown in
[0103] The molecular weight of the oxidized alginates of Examples 1, 2 and 3 was tested with a Shodex PW.sub.XL 4000 column (MW up to about 300,000 based on PEG standards), using a 0.1 M NaNO.sub.3 solution in water as the eluent. Samples were prepared in water with 0.1 M NaNO.sub.3 at concentrations of about 5 mg/ml.
[0104] For Example 1 (5% ox), M.sub.n was 89,000, M.sub.w was 247,100 and polydispersity was 2.77.
[0105] For Example 2 (10% ox), M.sub.n was 69,900, M.sub.w was 205,300 and polydispersity was 2.94.
[0106] For Example 3 (15% ox), Mn was 56,600, M.sub.w was 167,000 and polydispersity was 2.95.
Preparation of Hydrogels
[0107] Oxidized alginate samples were weighed into 1.5 mL Eppendorf tubes. To prepare alginate solutions of 2.5% (w/v), PBS was added and the solution was mixed for 30 min on a thermoshaker at RT (2000 rpm). Unless indicated otherwise, crosslinker solution was added (prepared in PBS) to prepare hydrogels with equimolar concentrations of aldehyde/crosslinker functionalities with a final alginate concentration of 2% (w/v).
[0108] Solutions were quickly transferred to polydimethylsiloxane molds with a disc geometry of 12 mm in diameter and 2.0 mm in thickness. Coverslips were placed on top of gel solutions during the gelation process to ensure hydrogels have flat top surfaces and homogeneous thickness. Gelation was left to occur for 30 min at room temperature and then overnight at 4° C. before rheological measurements were carried out.
TABLE-US-00001 Example reference Oxidized alginate Crosslinker 5% ox - Hydrazone Example 1 AADH 5% ox - Oxime Example 1 PDHA 5% ox - Semicarbazone Example 1 HDCA 10% ox - Hydrazone Example 2 AADH 10% ox - Oxime Example 2 PDHA 10% ox - Semicarbazone Example 2 HDCA 15% ox - Hydrazone Example 3 AADH 15% ox - Oxime Example 3 PDHA 15% ox - Semicarbazone Example 3 HDCA
All experiments resulted in self-standing hydrogels.
Measurements
Rheological Measurements
[0109] Rheological measurements of hydrogels were carried out using an Anton Paar MRC 702 at 23° C. using a parallel plate geometry with bottom and top diameters of 50 mm and 12 mm respectively. During loading, the experimental gap size was set when a threshold normal force was reached; 1 N for stiffer gels and 0.1 N for softer gels. This ensures good contact with the plates, prevents slippage, and increases the sensitivity of measurements by increasing the torque response. Samples were protected against evaporation by the addition of 2-3 drops of distilled water.
[0110] Oscillatory strain amplitude sweeps were conducted with strains from 1% to 800% at a frequency of 10 rad/s. Oscillatory frequency sweeps were performed from either 0.1 rad/s or 1 rad/s up to 100 rad/s. Step-strain measurements were undertaken to evaluate the self-healing capacity of hydrogels. Samples were subjected to 3 cycles, each consisting of 1% strain at 10 rad/s for 180 seconds followed by 600% strain at 10 rad/s for 100 seconds.
Cell Encapsulation/Seeding and Viability Assays
[0111] ATDC5 chondrocytes cells were cultured at 37° C. under a 5% CO.sub.2 atmosphere in Dulbecco's Modified Eagle's Medium-F12 (DMEM-F12, low glucose) supplemented with 10% (v/v) fetal bovine serum (FBS) and 1% (v/v) pen/strep. Cells were washed with PBS, trypsinized (0.05%), centrifuged, and then resuspended in a 10% ox-alg solution. They were subsequently mixed with crosslinker to yield a homogenous mixture of 2% (w/v) alginate containing 4×10.sup.6 cells/mL. 50 μl of the alginate mixture was transferred to a polydimethyl siloxane (PDMS) mold with a disc geometry of 12 mm in diameter and 2.0 mm in thickness. Gels were transferred to a non-adherent 24-well plate. Dulbecco's Modified Eagle's Medium-F12 (DMEM-F12, low glucose) supplemented with 10% (v/v) fetal bovine serum (FBS) and 1% (v/v) pen/strep was refreshed every two days.
Viability Assays
[0112] For live-dead assays, cells were stained with calcein AM/ethidium homodimer Live/Dead solution according to the manufacturer's instructions on days 1, 4 and 7. For the metabolic assay, PrestoBlue solution (10% (v/v) in DMEM-F12, supplemented with FBS) was added and cells were incubated for 2 h in the dark at 37° C. At each time point, 100 μl was collected from each well and the fluorescence intensity was recorded using microplate reader at an excitation wavelength of 530 nm and an emission wavelength of 590 nm.
Cell Spreading
[0113] Alginate gels were prepared as described in section above. Briefly, oxidized alginate was dissolved in PBS and aminooxy terminate RGD peptide was coupled to the network using oxime ligation chemistry. The final RGD ligand concentration was set to 1000 μM with 2% (w/v) oxidized alginate. Equimolar concentrations of crosslinkers (relative to aldehyde functionalities) were added and mixed uniformly. 25 μl of the oxidized alginate mixture was transferred to a 96 flat bottom black well plate, centrifuged at 1500 RCF for 5 minutes to form a uniform layer on the bottom and left to crosslink for 45 minutes. HDF cells were seeded on top of the gel with a cell density of 100 k/gel and cells were fixed using 4% PFA prior to imaging.
Bioprintability Viability
[0114] For cell viability (live-dead) after bioprinting, 10% ox-alg hydrazone hydrogels containing an ATDC5 cell suspension were prepared as mentioned above. A cell-laden solution was loaded into a 3 mL cartridge and placed at 37° C. for 1 hr. The cartridge with a G25 conical needle attached to it was then placed onto a BioScaffolder (GeSiM-Gesellschaft für Silizium-Mikrosysteme mbH, Germany). Bioprinting was carried out to create a four corner polygon with a radius of 2.0 mm, comprising 2 meandered strands placed at 1.0 mm apart. Single layer constructs with a height of 0.2 mm were created. The pressure was set to 140 kPa and extrusion was performed at 5.0 mm/s. Scaffolds were printed in 12-well non-treated cell culture plates. Live-dead viability assay were carried out after 24 hours as mentioned above.
Stiffness
[0115] As seen in the frequency sweep plots in
[0116] To investigate the effect of the degree of oxidation (DOX) on stiffness, 5% ox-alg, 10% ox-alg and 15% ox-alg gels were made using the hydrazone crosslinker (shown in
Viscoelasticity
[0117] The frequency sweep shown in
Self-Healing
[0118] Self-healing was initially visualized in the lab for the 15% ox-alg gel. In a glass vial, the gel network was broken using a spatula and self-healing was observed over time via the vial inversion method. The semicarbazone self-healed in≈5-15 minutes while hydrazone took≈30-45 minutes to self-heal. The oxime gel did not self-heal, though interestingly it formed a gel slurry after 72 h, once the network was broken.
[0119] To visualize self-healing macroscopically for the 10% ox-alg gel, two disk shape solid gels with different colours (red and green) were made. For a given crosslinker, each pair of gels was cut into 2 halves and then put back into contact within 5 minutes. We observed that the semicarbazone gels self-healed faster than the hydrazone gels and that the oxime gels did not self-heal. After 4 hrs, semicarbazone and hydrazone gels self-healed and the gel boundaries became obscured. Self-healed gels could be stretched using tweezers after 24 hrs: The semicarbazone gel interface stayed stable under stretching force; however, upon overstretching the hydrazone gel showed cracks across the interface.
[0120] In order to investigate the self-healing behavior more thoroughly, shear rupture-self-healing cycles were carried out on the rheometer. Initially, stain sweep experiments were carried out to determine the amount of strain needed for gel rupture. These gels proved to be surprisingly tough, with the crossover point for all gels being between 100% and 400% strain (
[0121] Upon rupture, the storage and loss moduli inverted and the storage moduli dramatically decreased (<10 Pa). Upon recovery, two-phase self-healing recovery was observed: i) rapid bond reformation under 20 secs upon removing the rupture strain, and ii) a slower recovery of stiffness observed during the next 160 secs. The rapid bond reformation regained a majority of the network stiffness≈70% (820 Pa from 1160 Pa) and≈40% (131 Pa from 356 Pa) of their initial storage moduli compared to≈10% and ≈5% in the slower recovery phase for semicarbazone and hydrazone crosslinks, respectively. Interestingly, crosslinks recover≈10% stronger after 2.sup.nd and 3.sup.rd rupture cycle compared to 1.sup.st rupture cycle.
[0122]
[0123] To see the effect of crosslinking density on self-healing, 10% ox-alg with 4-mole equivalents were compared to 1 mole equivalents of hydrazone crosslinks. Immediately apparent, the 1 mole equivalent of crosslinker forms a stiffer gel (350 Pa) with a significantly lower 200 Pa compared to the 4-mole equivalent crosslinker gel. The results are shown in
Cell Viability
[0124] ATDC5 chondrocytes cells were used for cell viability studies (live-dead and metabolic activity) as they are known to survive in gels without biochemical cues (e.g. RGD). ATDC5 were encapsulated (3D) within 10% ox-alg gels and cells were stained and imaged using an inverted fluorescence microscope to evaluate cytotoxicity after 1, 4, and 7 days. Shown in
[0125] To confirm the high viability for chondrocytes seen during the live/dead assay, a prestoblue assay was run to investigate the metabolic activity of the cells within the gels over 168 hrs (7 days) (
[0126] Further, human mesenchymal stem cells (hMSCs) were seeded on top of hydrazone gels. hMSCs had a round morphology after 1 hour (
[0127] Islet cell aggregates were encapsulated within hydrazone, semicarbazone and oxime hydrogels and results were compared to a positive control (cell aggregates on agarose well plate). Cell metabolic activity was recorded after 24 hours and normalized to total DNA. Islet cell aggregates are more metabolically active in hydrazone gels compared to other gels and a control. The results are shown in
Cell Spreading
[0128] Alginate possesses no active adhesion sites to interact or attach to mammalian cells, but cell adhesion and interaction can be promoted through the conjugation of cell adhesion ligands (e.g. RGD). Hydrogels were biofunctionalized by incorporating aminooxy-terminated RGD peptide (1000 μM) to the 10% ox-alg hydrogel formulation. To investigate whether the crosslinks with different viscoelasticity have an influence on cell spreading, human dermal fibroblasts (HDFs) were seeded on top (2D) for 24 hrs. Cells were imaged in bright field using inverted microscope (see
[0129] We noticed a marked effect on the amount of spreading on the different DCvC crosslinked gels. Cell spreading was found to increase for networks crosslinked by bonds with a higher hydrolysis rate (k.sub.−1), namely more dynamically rearranging crosslinks. HDFs seeded on the dynamic hydrogels (semicarbazone and hydrazone) showed a spindle shape, increased spreading, and an elongated morphology, with the hydrazone networks showing a more elongated morphology than the semicarbazone. For the oxime hydrogels, only rounded morphologies typical of cells in elastic hydrogels were observed. The same trend was observed with HDF were cultured within gels (3D). Observing larger cell spreading on viscoelastic matrices (semicarbazone and hydrazone) suggests that rearrangement of dynamic crosslinks influenced cell spreading. These results will be further explored in the future and our current hypothesis is that microenvironment clustering of adhesive ligands, or stress relaxation plays a significant role.
[0130] Similar results can be shown in a 3D structure.
Printing
[0131] With control over the materials properties, self-healing, cell viability, and biofunctionalization in these materials, we next investigated the injectability of these hydrogels. To assess the shear-thinning capability of the 10% ox-alg with different crosslinkers, we attempted to inject these materials from a syringe through a 25 gauge needle (260 μm i.d.). The hydrazone and semicarbazone hydrogels were injectable through the needle with only the force of the hand and formed intact smooth fibers due to their self-healing capability. Interestingly, the oxime gel was also found to be injectable, but the injected fiber was a non-continuous gel slurry upon injection. Hydrogels made from the 15% ox-alg with both hydrazone and semicarbazone were also observed to be injectable; however, the 15% semicarbazone hydrogels did not produce smooth fibers and required more force for injection. These initial experiments encouraged the exploration for use as bioinks for bioprinting and forecast their suitability as drug or cell delivery vehicles.
[0132] While both hydrazone and semicarbazone gels showed some initial printability, the semicarbazone gels required significantly higher pressures and larger needle diameters. Consequently, the hydrazone gels were deemed more likely to support cell viability and were further optimized for bioprinting. A simple grid structure was employed to study the effects of deposition speed and extrusion pressure on printability. Using different deposition speeds and extrusion pressures, we used the 10% ox-alg hydrazone hydrogels (2% w/v) to deposit 2-layered grid structures via a 0.25 mm diameter conical needle. Extrusion of the hydrogel at 115 and 120 kPa were observed to be more homogeneous and better defined structures were extruded at a speed of 5 mm/s, as opposed to the partial and inhomogeneous hydrogel fibers bioprinted at 7 mm/s (
[0133] This could be expected as the bioprinting speeds employed should allow ample time for appropriate amount of material to be deposited and placed on substrate. Similarly, extrusion pressure was optimized to tune the amount of deposited hydrogel and 3 different pressures (115, 120, and 140 kPa) were tested. A pressure of 140 Kpa was found to be the optimal pressure for fiber extrusion among the tested values.
[0134] Printing was also tested with κ% ox-alg with 2% (w/v) and a lower concentration (1% (w/v)) of the 10% ox-alg. Since these formulation form softer and less viscous gels, smaller diameter needle and low extrusion pressures were tried for printing. Though both formulations showed promising 2-layered constructs, the integrity of the structure was compromised owing to their softer nature (Figures of printed structures are shown in
[0135] Our aims to create soft tissue constructs prompted the exploration of either more life-like or solid structures. Utilizing the optimized pressure (140 kPa) and deposition speed (5 mm/s), more complex and self-supporting structures were printed with 10% ox-alg gels with oxime, semicarbazone, and hydrazone different crosslinkers by extrusion through a 25G needle.
[0136] While the recreation of the vascular tree was found possible, the printing of sharp angels and closely spaced or parallel lines resulted in occlusion and merging as found in the MERLN name. Although these bioinks could be optimized for better bioprint fidelity, the bioprinted structures are self-supporting while being deposited from dynamic and viscoelastic gels. Our initial optimization attempts with these materials formulations do show promising results, yet may need significant optimization, utilizing temperature sensitivity of hydrazone crosslinks or reinforcement from a Ca.sup.2+bath.
[0137] To increase bioprinting fidelity and print self-supporting structures with continuous deposition of material, printability was also tested by manually disrupting the gel network before printing. Preprinting network disruption allowed uniform deposition of material at seven mm/s using 150 kPa, and this modification resulted in a vascular structure with better printing resolution and uniformity (shown as b-6 in
[0138] The viability of 10% ox-alg (2% (w/v)) hydrazone gels with ATDC5 was evaluated 24 hrs after bioprinting and compared to the control, without bioprinting (shown in